Global Technology – December 2014

Let’s focus on this month’s most important advances in technology.

As recently announced in the journal Cell, Harvard stem cell researchers have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated 3 million Americans at a cost of about $15 billion annually.

Type 1 diabetes is an autoimmune metabolic condition in which the body kills off all the pancreatic beta cells that produce the insulin needed for glucose regulation in the body.

This content is for BUSINESS BRIEFINGS members only.